· The patient who had end stage heart failure travelled from Haryana to Bengaluru to get this surgery done by Dr. Kumud Dhital at Apollo Seshadripuram
· Karnataka is one of the leading states in India in terms of organ donations
Bengaluru, 16th April 2025: A 40-year-old resident of Haryana, who had end stage heart failure, was given a new lease on life through a complicated heart transplant surgery performed at Apollo Hospital, Seshadripuram, Bengaluru.
The patient, who is a father of two and the sole breadwinner for his family, was diagnosed with Dilated Cardiomyopathy (DCM) with severe bi-ventricular dysfunction, a condition where both the left and right pumping chambers of the heart fail to function properly. His condition required frequent hospital admissions for recurrent heart failure, causing a rapid decline in his quality of life. After extensive treatments and worsening symptoms, he flew down to Bengaluru with the support of a specialized medical team to get the heart transplant done by Dr. Kumud Dhital, Program & Surgical Director for Heart & Lung at Apollo Seshadripuram.
Commenting on the patient’s condition while presented at the hospital, Dr. Kumud Dhital said, “Upon arrival at Apollo Hospitals, he showed severe symptoms of advanced heart failure. He required immediate intervention, including the insertion of an Intra-Aortic Balloon Pump (IABP) to stabilize his condition. Aggressive fluid management was performed to remove over 20 litres of excess fluid before he was deemed fit for a transplant.”
After a month-long wait, a suitable organ became available, and he underwent the heart transplant procedure, performed by Dr. Kumud Dhital with support from Senior Cardiothoracic & Vascular Surgeons Dr. Anand Subramaniyam Dr. Manoj Kumar & Dr. Prakash Ludhani, and anesthetists Dr. Pradeep Kumar and Dr. Srinivas Dhulipala. Owing to the concerted efforts of the multidisciplinary team, both the surgical procedure and post-operative recovery progressed smoothly. The patient was subsequently discharged within few weeks and returned to Sonipat, Haryana, to reunite with his family.
The patient’s brother expressed his gratitude, “It’s been an emotional journey, but seeing my brother healthy again is beyond words. We are deeply grateful to the donor family for giving my brother a second chance at life.”
While talking about the importance of organ donation, Dr. Kumud Dhital said, “this story highlights the transformative impact of organ donation on patients with end-stage organ failure. This patient’s survival was made possible by the selfless decision of a donor’s family and the coordinated efforts of donor coordination, organ registry, transplant teams, and other healthcare professionals. It also underscores the urgent need for greater awareness and participation in organ donation programs.”
Head of Apollo Hospitals Seshadripuram Mr. Uday Davda said “We Thank Jeevasarthakathe for their exceptional coordination in making organ donation a streamlined process in Karnataka. This is what had lead the state to be awarded the second-best state for organ donations in 2023 by the central government. We can restore many lives and families if the public at large come out to donate organs.”
January 16, 2025, Bengaluru: Cancer remains the illness most feared across the globe. To combat these ongoing challenges, cancer diagnostics techniques and technologyadvancements are helpingearly detection rates, improving life expectancy, and bringing us closer to cancer care.
In this ongoing fight against cancer, treatments are being revamped by adopting modern technologies that have moved cancer care forward by leaps and bounds and enhancing patients’ quality of life. Among these advancements, Robotic Nipple Sparing Mastectomy (RNSM) combined with Tiloop implant reconstruction stands out as a groundbreaking development in breast surgery.
Apollo Cancer Centre (ACC), Bengaluru, successfully conducted India’s first Robotic Nipple Sparing Mastectomy-with Titanised Polypropylene (TPP) Mesh for breast implant reconstruction on a 37-year-old Latha who was diagnosed with right breast cancer in April 2024. The size of her lump was 3 cms x 2.5 cms in size with Lymph nodes in the axilla enlarged.
The expert team lead by Dr. Jayanti Thumsi, Lead & Robotic Breast Surgeon, Apollo Cancer Centre, Bangalore, gave her chemotherapy (NACT) x 16 cycles. She is BRCA negative
In Sept 2024, the team performed RNSM with TiLoop and breast implant reconstruction. She was discharged with a drain which was removed after a week. Her tubes and ovaries were also removed as she was Estrogen Receptor (ER) and Progesterone Receptor (PR) positive and Human Epidermal Growth Factor Receptor2 (Her2) was negative. Subsequently, she was also given radiation therapy which ended in Nov 2024. She’s now on Hormone Therapy and doing very well.
Another cancer winner, a 48-year-old Sneha T(name changed) was diagnosed with right cancer breast in October 2024. She was treated with RNSM with TiLoop and implant reconstruction done in November 2024.
She had Mucinous ca breast no chemo or radiation therapies were given. She is currently on Hormone Therapy and doing well.
Sneha T shared her thoughts on the treatment, saying, “I am glad I made the right decision. to undergo RNSM with implant reconstruction using Tiloop Mesh. Initially, I was anxious about losing my breast as part of the cancer treatment. Today, I am immensely satisfied- not only am I free from the disease, but my breast has been beautifully reconstructed, and the symmetry on both sides has been perfectly maintained.”
Robotic nipple-sparing mastectomy is a minimally invasive procedure designed to remove breast tissue while preserving the skin envelope, nipple-areola complex (NAC), and natural breast contours. Performed using the da Vinci Surgical System, this approach provides surgeons with enhanced dexterity, precision, and 3D high-definition imaging for meticulous dissection. The use of small, hidden incisions, ensures minimal visible scarring. This technique offers multiple advantages, including oncological safety through a thorough removal of breast tissue, aesthetic preservation of the NAC and skin, and reduced trauma leading to decreased pain, blood loss, and recovery time
The Tiloop Bra, a titanium-coated polypropylene mesh, is a transformative addition to RNSM, enhancing reconstructive outcomes. Acting as a scaffold, it provides structural support to hold the implant in place, prevents displacement, and promotes seamless tissue integration. Its blocompatible design minimizes the risk of complications such as capsular contracture, while its ability to enhance symmetry and shape ensures a more natural appearance.
The workflow for this combined procedure begins with preoperative planning, including imaging studies and consultations to assess the tumor’s location, size, and the patient’s sultability for RNSM. During the robotic surgery, a small incision allows for precise tissue removal while preserving the NAC. Subsequently, the TiLoop mesh is placed along with the breast implant to reconstruct the breast. Postoperative care involves monitoring for healing and recovery, with most patients resuming normal activities within a few weeks,
The combined benefits of RNSM and Tiloop reconstruction include a minimally invasive approach that reduces scarring and recovery time, improved cosmetic results due to NAC preservation, greater patient comfort through less postoperative pain, and a lower risk of implant-related complications like migration or contracture.
Traditionally, breast reconstruction in India has predominantly utilized autologous tissue techniques, notably the Latissimus Dorsi (LD) flap. This method involves harvesting tissue from the patient’s back, including the latissimus dorsi muscle, to reconstruct the breast mound. The procedure is complex, involving extensive tissue dissection, leading to increased surgical time, higher chances of postoperative complications, and prolonged recovery periods.
Dr. Jayanti Thumsi, Lead Surgeon and Robotic Breast Surgeon at Apollo Cancer Centre, Bangalore, and the first in India to treat 16 women with breast cancer using the TiLoop Mesh, shared her insights: “Robotic nipple-sparing mastectomy with TiLoop implant reconstruction represents the perfect blend of precision technology and innovative reconstructive techniques providing women with a safer and less invasive reconstruction option, and encouraging more Indian patients to consider reconstruction post-mastectomy. This advanced approach not only ensures effective cancer clearance but also preserves a woman’s femininity, significantly enhancing her quality of life after breast cancer treatment. Ultimately, the goal is to address the physical disease while also prioritizing the patient’s emotional well-being.”
Mr Dinesh Madhavan, President Group Oncology and International, Apollo Hospitals Enterprise Ltd (AHEL) said: “Robotics has revolutionized cancer care, implementation of advanced materials and designs along with the integration of imaging and visualization technologies have enhanced surgical accuracy and faster recovery. The use of Titanszed Polypropylene Mesh aids in surgical decision-making by improving the recognition of minute and complex anatomical structures. Advancements through Robotic procedures like Robotic Nipple Sparing Mastectomy with Tiloop and breast implant reconstruction, have led to faster recovery and fewer complications in patients. This is a testament to the persistent pursuit of progress in healthcare.”
Dr Manish Mattoo, CEO Karnataka & Central Region, AHEL, said, “The introduction of TiLoop mesh is likely to address many concerns that have traditionally deterred Indian women from opting for reconstruction. Its minimally invasive nature, combined with better outcomes and shorter recovery times, makes it an attractive option for patients hesitant about traditional procedures. Moreover, the positive experiences of early adopters can help combat cultural stigmas and encourage others to consider reconstruction.”
This innovative approach exemplifies the continuous evolution of medical technologies aimed at enhancing patient outcomes and experiences in the realm of breast cancer treatment.
In India, breast cancer rates are notably high, especially among young women, constituting 48% of cases.
Bangalore, September 13, 2024: In a remarkable demonstration of resilience and hope, Mrs. Sunita (name changed), a corneal transplant recipient, joined Dr. Amod Nayak, Head of Clinical Services, and Dr. Srinivas L. Gombi, Dean of Academics at MVJ Engineering College, to flag off a walkathon today aimed at raising awareness about eye donation. The event, organized by Dr. Agarwal’s Eye Hospital in collaboration with MVJ Engineering College, sought to underscore the critical need for corneal donations and inspire the community to pledge their eyes. The walkathon brought together over 80+ students, faculty members, doctors, and hospital staff, all committed to spreading the message of eye donation. Participants carried placards with thought-provoking messages, advocating for the cause and encouraging the community to give the gift of sight to those in need.
Dr. Amod Nayak, Head of Clinical Services at Dr. Agarwal’s Eye Hospital, emphasized the pressing need for eye donations, stating, “There are thousands of people across the country waiting for corneal transplants. Unfortunately, the demand far exceeds the supply, largely due to a lack of awareness. Through this walkathon, we aim to educate the public and dispel misconceptions surrounding the eye donation process.”
Dr. Srinivas L. Gombi, Dean of Academics, also stressed the importance of the initiative, saying, “Awareness is key to breaking down myths and inspiring more people to pledge their eyes. Through education and advocacy, we can close the gap and ensure that individuals in need of corneal transplants receive this life-changing treatment. I urge everyone to support this cause and join the mission to restore sight.” “Eye donation is a simple yet profound way to make a lasting impact. A single pair of donated eyes has the potential to restore vision to two individuals, offering them a fresh start in life. The success of today’s walkathon reflects the increasing awareness of the importance of eye donation. By sharing the stories of corneal transplant recipients like Mrs. Sunita, we hope to inspire others to take action and contribute to this life-changing cause” said Dr. Amod Nayak. Dr. Agarwals eye hospital has conducted 15+ awareness events during the fortnight with close to 2000 volunteers to help spread the message of Eye Donation. For any questions on eye donation or to pledge please visit https://www.dragarwal.com/eye-donation/ or call +919444444844
Collaboration between the two leading healthcare providers is aimed at benefiting patients in India and across the region
Bangalore, India July 12, 2024: Ramaiah Memorial Hospital (RMH), one of India’s leading multi-super-specialty quaternary care hospitals based at Bengaluru, Karnataka, has signed an exclusive agreement with the New York-based Mount Sinai Health System today, marking the beginning of a transformative partnership that aims at advancing healthcare services through collaborations in clinical excellence, quality of care, research, innovation and technology. The collaboration, formalized through a long-term a collaboration agreement, reinforces the commitment of both institutions by provisioning Mount Sinai’s support to the Ramaiah Memorial Hospital to further advance the development of its clinical competencies and centers of excellence in a host of select specialty areas, including, but not limited to, Oncology, Cardiology, Neurosciences, Urology-Nephrology, and other Clinical Specialties. A key component of the Ramaiah-Mount Sinai collaboration will include the periodic review of Ramaiah’s complex clinical cases by both Ramaiah’s and Mount Sinai’s top clinical experts across various clinical specialties to assist Ramaiah in identifying the best treatment options for patients. Speaking on this momentous occasion, Dr. M. R. Jayaram, Chairman – Gokula Education Foundation shared, “At Ramaiah Memorial Hospital, we are excited to announce this significant collaboration with Mount Sinai in New York which is aimed to advance clinical excellence, enhance patient care, safety, quality, further medical innovation and technology, and take the standard of the overall healthcare offerings to the next level.” Speaking on the occasion, Dr. Szabi Dorotovics, President of Mount Sinai International said, “It is in the spirit of Kempegowda – the founder of Bengaluru – who, to this day, is remembered for enabling the citizens of Bengaluru enhance their development and prosperity, that Mount Sinai and the Ramaiah Memorial Hospital have now forged our long-term collaboration and partnership. Together, we seek to provide the citizens of Bengaluru, and the State of Karnataka, with the highest international standards of healthcare to enhance their wellness, and thereby, their prosperity.”
Dr. David L. Reich, President – Mount Sinai Hospital and Mount Sinai Queens, speaking on the occasion mentioned emphasized that “The pairing of Mount Sinai with the Ramaiah Memorial Hospital is an ideal partnership combining two leading institutions with long histories that are dedicated to medical education, clinical innovation, and an unwavering focus on providing world-class healthcare services to their patients. In the coming years of our collaboration, it will be my honor to facilitate Ramaiah’s access to Mount Sinai’s clinical and management expertise and best-practices, and I look forward to our continuously-evolving mutual engagement.” Ramaiah Memorial Hospital and Mount Sinai look forward to a fruitful collaboration that will set new benchmarks in healthcare delivery and positively impact the lives of patients in India and in the sub-continent. Shri M R Sreenivasa Murthy, Chief Executive, Gokula Education Foundation (Medical) said, “Our commitment to clinical excellence is a testament to our continuous strive to improve and innovate. We invest in the latest technology and techniques to ensure that our patients have access to the most advanced treatments available, and we are constantly working to improve our processes and procedures to deliver better outcomes for our patients. The collaboration with Mount Sinai in New York is a step towards taking this commitment further for the benefit of our patients and the clinical fraternity.” Dr SC Nagendra Swamy, President – Ramaiah Memorial Hospital, emphasized the hospital’s dedication to clinical excellence and continuous improvement, stating, “With our strategic collaboration with Mount Sinai Hospital New York, our offerings as a leading healthcare provider in the region will be compounded manifolds and will open doors for providing patient care, safety and quality excellence along with possible medical research for our clinicians as well as to learn and acquire the latest clinical exposures from the best minds at Mount Sinai via virtual webinars, workshops and on-site case reviews/discussions as part of the collaboration initiative. Ramaiah is committed to empowering its team of healthcare professionals through advanced training programs, workshops, and access to the latest medical research, knowledge, techniques and technologies.”
Aster CMI Hospital, Bengaluru is the first in South India to achieve the Platinum Certification (highest level) Also makes the hospital the first in Karnataka to receive the NABH Digital Standard Certification
26 June 2024, Bengaluru: Aster DM Healthcare, one of the largest integrated healthcare providers in India is proud to announce the recognition received for Aster CMI Hospital, Bengaluru as the first hospital in South India to achieve the top-tier Platinum Certification for Digital Health Standards from the National Accreditation Board for Hospitals & Healthcare Providers (NABH). This distinguished certification also makes Aster CMI the first hospital in Karnataka to be accredited under NABH’s new digital standards framework. The NABH Digital Health Standards, launched in 2023, are pioneering in India, specifically designed to assess hospitals based on their digital maturity and integration of advanced technologies in healthcare. These standards aim to enhance clinical care quality, patient safety, and overall operational efficiency by encouraging the adoption of digital health processes. Digital health innovations such as telemedicine, electronic health records (EHRs), mobile health applications, wearable technology, and artificial intelligence are critical components in transforming healthcare delivery. These technologies enable more effective health management, personalized and efficient care, and improved health outcomes. Aster CMI Hospital has successfully implemented several key digital health initiatives contributing to this accreditation. One of the notable advancements is the comprehensive Electronic Medical Records (EMR) system, which ensures secure and accessible patient data management. The Online Quality Management System has also been pivotal, facilitating quality audits, clinical pathway compliance, and real-time dashboard monitoring. Another significant implementation is Aster Insight, a robust feedback mechanism that continuously improves patient services by capturing and analyzing patient experiences. Additionally, Aster CMI’s telemedicine services extend healthcare access to remote and underserved areas, ensuring continuity of care and expanding the hospital’s reach. Apart from this, initiatives like online incident management system, Oracle based inventory management, lab information system, digital payments, remote patient monitoring and more played a key role in getting the accreditation. Dr. Nitish Shetty, CEO of Aster DM Healthcare, India, expressing his pride in this achievement, said, “We are honored to receive the Platinum certification from NABH, a testament to our unwavering commitment to excellence in healthcare. This achievement reflects our team’s dedication to patient care and safety, ensuring we meet the highest standards in our industry. We remain steadfast in our mission to deliver compassionate, innovative healthcare solutions, empowering healthier lives. This recognition underscores our promise to the communities we serve and motivates us to continually raise the bar.” Mr. Sreeni Venugopal, Chief Information Officer, Aster DM Healthcare, shared his enthusiasm and said, “I am proud of our team’s diligent efforts in achieving this accreditation. This recognition validates our commitment to leveraging technology for enhancing patient care and operational efficiency. It reaffirms our role in safeguarding sensitive healthcare data and maintaining robust IT infrastructure. We are dedicated to advancing healthcare through innovation and secure digital solutions, ensuring our patients receive the highest standard of care.” Earlier this year, Aster CMI Hospital was also recognized with the Best Contact Centre of the Year 2024-2025 award at the BPO & Contact Centre Summit and Awards 2024. This accolade highlights the hospital’s commitment to delivering exceptional patient service and operational excellence. Looking ahead, Aster CMI Hospital is committed to expanding its services, advancing medical research, and enhancing patient experiences. The Platinum certification serves as a foundation for continuous improvement, with the hospital striving to set new benchmarks in healthcare excellence.
City Today News 
You must be logged in to post a comment.